remap-cap
@remap_cap
Followers
4K
Following
621
Media
113
Statuses
536
Using an innovative trial design to efficiently evaluate multiple interventions simultaneously. Research is in our DNA #remapcapfamily https://t.co/xvsFGJlEiK
Joined March 2017
REMAP-CAP's @DerdeLennie adds her voice to a beautiful celebration of #InternationalDayofWomenandGirlsinScience 👇
🎉 Happy #InternationalDayofWomenandGirlsinScience! 🧑🏽🔬 Watch our collaborators talk about what inspired them to embark on a journey in science. @AnaCHdez_ @AZinkernagelLab @DerdeLennie @sandulescu_oana @ESCMID @UZH_en @CHULimoges @IenI_UMCUtrecht @UMCU_Intl @HeidelbergU @UN
1
1
5
REMAP-CAP expanded immensely during the #COVID19 #pandemic, but in many regions it predates that period. 🇯🇵 @RemapCap Japan commenced in 2020 & has had an outsized impact on #clinicalresearch in the country, paving the way for other adaptive platform trials. #10YearsREMAPCAP
0
0
2
🫁 Today we mark #WorldPneumoniaDay2024. The #remapcapfamily has been tackling community-acquired #pneumonia for a decade now, and our joint efforts have positively impacted many lives around the world. #10YearsREMAPCAP
#infectiousdiseases #clinicalresearch #covid19
0
5
12
Keeping patients, their families and the public engaged is a strength of REMAP-CAP. 🇵🇰 The Pakistani Patient & Public Involvement & Engagement group's 2024 summit gained national news coverage and presented networking opportunities. 👉 https://t.co/9somk69lvW
#10YearsREMAPCAP
0
0
3
Empowering Patients - Revising Informed Consent Processes for Critical Care Trials in Pakistan Our public group has worked with us to make informed consent for @MegaROXtrial and @remap_cap more culturally sensitive and relevant in the Pakistani context
1
2
5
What does being a pragmatic trial mean in South Asia? We evaluated 3 international trials (@remap_cap @MegaROXtrial RECOVERY) Absent post-discharge follow up and poor physician and public understanding of trials constrained their incorporation into usual care
1
1
1
Our friends at the Dutch hospital @UMCU_Intl highlight REMAP-CAP's exceptional contribution to tackling community-acquired #pneumonia & #COVID19 🫁 Read the article 👉 https://t.co/h8eIO6fLbz
#10YearsREMAPCAP
@Lennie333 @MarcBonten @IenI_UMCUtrecht
0
1
5
▶️ Learn about platform #clinicaltrials in Module 5 of our Adaptive #ClinicalTrial Designs series! ➕ PRACTical design & RECOVERY, @remap_cap & NeoSep1 trials With the brilliant @pmozgunov @thomas_jaki @Lennie333 Sarah Walker & @biju_sgul Read more 👉🏼 https://t.co/uR7VJRXq7X
0
7
9
🚨 Last chance to register for the Ecraid x @ESCMID Better Methods postgrad course. Sharpen your tools with the help of top experts like @MarcBonten. Read more 👉🏾 https://t.co/D1ISbCqCq9 📅 22-24 October 2024 📍 Belgrade, Serbia ⏳ Registration closes 4 October
0
7
10
REMAP-CAP team members attended the Federated Platform Trials meeting in Dublin organised by @ICCCTN, @ISARIC1 & @AcuteCareTrials. The focus was on principles to enable platform #clinicaltrials to federate effectively, particularly in the field of #criticalcare.
0
1
16
Thank you to our fantastic ICU team on #Red4Research day for their ongoing support with Clinical Trials @Airways_3 @AbbruptTrial @GenomiccStudy @iRehabTrial @remap_cap ❤️
0
3
9
Thrilled to have @RienkPypstra from our @COMBACTE-CARE days, visit and share his insights on Ecraid's role in #infectiousdiseases research. We're committed to being a hub for clinical trials, data management, real-world evidence & #outbreakresponse. @tranScripLtd #PublicHealth
0
3
2
🇵🇰 @Zuedu is one of 7 sites in Pakistan currently participating in REMAP-CAP. Its Patient and Public Involvement & Engagement group recently produced a great video explaining #clinicaltrials in Urdu and with locally relevant graphics. Check it out 👉 https://t.co/QMqTDuKuJV
0
0
2
🚩 Major REMAP-CAP milestone: 14.000 patients have been enrolled in the trial globally. A big THANK YOU to the whole #remapcapfamily for the dedication and commitment to improving outcomes for patients with community-acquired #pneumonia 👏🏻👏🏾👏🏼 #10YearsREMAPCAP
0
3
9
Attending the #ERSCongress2024? Join this postgrad course to hear @Lennie333 discuss the landscape of adaptive platform #clinicaltrials in #criticalcare and the REMAP-CAP trial 👇 @EuroRespSoc @UMCU_Intl @IenI_UMCUtrecht @EU_Commission
EU project sessions at the #ERSCongress2024 Join the experts on 7 September at 14:00 CEST for PG10 Postgraduate course Management of respiratory infection: lessons learnt from @Ecraid-Base clinical trials. Find out more: https://t.co/rLG2h5EsTv
0
1
2
▶️ Module 4 is out! It introduces 2 adaptive randomisation designs + 3 case studies: @ISPY2trial, @remap_cap & @ATTACC_CAP. Read about the content & speakers 👉🏾 https://t.co/un7TegFj7Y Access the module for free 👉🏼 https://t.co/XUYva5Wshc
0
3
5
There was a lot of discussion around the presentation of the @remap_cap steroids for non-COVID community-acquired pneumonia domain results at #CCR24 Steve Webb from @anzicsctg & Scott Berry from @BerryConsultant discuss their findings The data are presently unpublished
1
6
18
Those working on the REMAP-CAP trial in Europe are eligible for an attendance grant from @Ecraid. Follow the link below for details on how to apply 👇
📚 Experienced lecturers & motivated postgraduates will come together in the Serbian capital to dissect a wide variety of topics that are as relevant as they are practical. Attendance grants are available for @ESCMID and Ecraid members. Learn more 👉🏾 https://t.co/NVbBXT62F0
0
1
2
Professor Anthony Gordon, REMAP-CAP's UK Chief Investigator, has been awarded an MBE (Member of the Order of the British Empire) for his contribution to #criticalcare. Congratulations on this important recognition, @agordonICU 👏 https://t.co/ru6ErGi4gH
@imperialcollege
5
2
45